Clinical trial
Omega-3 Fatty Acids for MDD With High Inflammation: A Personalized Approach
NCT02553915 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Omega-3 Fatty Acids for MDD With High Inflammation: A Personalized Approach
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- December 31, 2015
- Completion date
- March 31, 2022
- Enrollment
- 61 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.